1393P Phase I/II clinical trial of combination of anti-PD-1 mAb, nivolumab with radiotherapy for unresectable and recurrent gastric cancer who failed to standard chemotherapy.

Authors :: Kono, K.
Mimura, K.
Ogata, T.
Yoshimoto, Y.
Yoshida, D.
Nakajima, S.
Sato, H.
Machida, N.
Yamada, T.
Watanabe, Y.
Tamaki, T.
Fujikawa, H.
Inokuchi, Y.
Onozawa, H.
Hayase, S.
Hanayama, H.
Saze, Z.
Katoh, H.
Oshima, T.
Suzuki, Y.
Source :: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS1053-S1054. 2p.
Publication Year :: 2021

Subjects :: *NIVOLUMAB
*STOMACH cancer
*CLINICAL trials
*RADIOTHERAPY
*CANCER chemotherapy

Full Text Access

Tools